Healthcare Liability in 2026: What NY Physicians Actually Face Now

Reviewed by Akili Hinson, Managing Principal
New York's medical malpractice environment in 2026 sits at the intersection of a decades-old statutory framework and a rapidly changing clinical delivery landscape. CPLR 214-a still governs the statute of limitations at two years and six months from the alleged act, omission, or the end of continuous treatment. Lavern's Law extended that window in 2018 for missed-cancer and malignant-tumor diagnoses to run from the date of discovery, capped at seven years from the alleged negligence. Those two statutes set the outer boundary of exposure, but three operational trends (telehealth jurisdiction, AI-assisted diagnosis, and cyber-adjacent professional liability) are where most NY physicians are underinsured in 2026.
TL;DR. NY malpractice limits written at $1M/$3M in 2020 are often inadequate against current verdict severity. Most NY hospital credentialing now expects $1.3M/$3.9M minimums per Section 18 Excess program eligibility. Tail coverage typically runs 150–200% of final annual premium, paid as a lump sum at departure. Telehealth across state lines raises both licensure and policy-territory questions. AI-assisted diagnostic tools do not shift liability off the physician. See our NY medical malpractice guide and tail-coverage explainer for the mechanics.
Why credentialing minimums drifted up
NY hospital systems and managed-care organizations have broadly converged on credentialing minimums of $1.3M per occurrence / $3.9M aggregate for physicians in the last five years, up from the older $1M/$3M benchmark. The practical driver is NY's Section 18 Excess Medical Malpractice Program, a state-administered layer of excess coverage above primary that traditionally attaches at $1.3M/$3.9M. Hospital credentialing departments align minimums with Section 18 attachment points because the excess layer is economically meaningful only when the underlying primary matches. For context on how the excess layer fits into the coverage stack, see our occurrence versus claims-made walkthrough and the tail-coverage explainer.
Verdict severity is the secondary driver. Published NY verdict data compiled across major carriers and jury-verdict reporters shows top-decile awards rising materially since 2020. Nuclear verdicts (over $10M) are now a recurring feature in specialties that historically saw moderate severity. For a worked example of how a $2M NY physician verdict actually flows through a claims-made policy, see the real cost of a $2M NY malpractice verdict.
Tail coverage: still the cleanup step most physicians underbudget
When a physician leaves a claims-made policy (resignation, retirement, carrier change), prior-acts exposure does not disappear. Tail coverage, formally called an extended reporting endorsement, covers claims filed after a policy ends for incidents that occurred during the policy period. NY carriers typically price tail at 150–200% of the final annual premium, paid as a single lump sum at departure. For a NY solo physician paying $18K in annual premium, that is a $27K to $36K one-time cost; for a surgical subspecialist at $50K in annual premium, the tail bill lands at $75K to $100K.
Three tail-adjacent decisions made at hiring, not at departure
- Who pays. The employment agreement should assign tail cost explicitly to either the physician or the practice. Silence is the single most common source of post-departure dispute we see in NY contract reviews.
- Free-tail triggers. Most NY carriers offer free tail on retirement after a minimum tenure (typically five to seven years on the carrier), on disability, and on death. Confirm these triggers on the policy declarations rather than relying on carrier marketing.
- Nose versus tail. Prior-acts (nose) coverage on the successor policy fully replaces the need for tail on the departing carrier, provided the successor's retroactive date runs back to the physician's original date of coverage. Negotiating nose at hiring is structurally cleaner than buying tail at departure.
The structural choice between tail at exit and nose on the new policy typically nets a similar total cost, but nose shifts the timing to the new carrier and the new employer's balance sheet. For NY hospital-employed physicians changing systems, nose is the more common path. For private-practice exits to locum, retirement, or out-of-state, tail is the typical fallback.
Telehealth: where the policy territory and the medical license diverge
Telehealth has become a standing feature of NY primary care, behavioral health, and specialty consultation since 2020, but the policy-coverage mechanics still trip physicians and practices at renewal time. Two questions must be answered together.
Where is the patient physically located at the time of the encounter
NY-admitted malpractice policies typically cover professional services rendered by a licensed physician within the policy territory. A NY-licensed physician conducting a telehealth visit with a patient physically in NJ at the time of the encounter raises a licensure question (NJ law governs medical practice within NJ, with limited telehealth exceptions under the Interstate Medical Licensure Compact) and a policy-territory question (does the NY policy respond to an encounter that originated outside NY). The two questions are separate but interlocking.
What the policy endorsement language actually says
Most NY-admitted carriers updated their forms between 2021 and 2023 to clarify telehealth territory. The updated language typically covers telehealth where the physician is licensed in the patient's state and the policy territory includes the state where the patient is located. Practices conducting multi-state telehealth should confirm the endorsement is on each physician's current declarations and that the roster of states matches the practice's licensure footprint. For cross-state credentialing context, see our guide to professional-liability service.
AI-assisted diagnosis: liability still runs through the physician
AI clinical decision-support tools, radiology-AI triage flags, and pathology-AI screening tools are now common in NY hospital systems and large practice groups. The liability question most physicians ask is whether the AI vendor absorbs exposure when an algorithm misses a finding. Current NY case law, and the broader US trend, treats AI tools as clinical decision support rather than decision makers. The physician retains the duty of care. The malpractice standard remains what a reasonable physician would have done with the same information set.
What to document
Three practical documentation habits reduce defensibility risk without slowing the workflow:
- The physician reviewed the AI output and applied clinical judgment rather than deferring to the tool.
- The clinical note reflects the physician's reasoning, including when the physician overrode or confirmed an AI flag.
- The practice's clinical policy defines how AI outputs integrate into the diagnostic workflow, including escalation paths when the tool flags high-risk findings.
AI-vendor product-liability claims are a separate and still-developing doctrinal area. The AMA and several state medical societies are actively tracking the emerging case law; the Federation of State Medical Boards has published preliminary guidance on AI in clinical practice. Physicians should not plan around AI-vendor indemnity as a primary liability shield.
Cyber-adjacent professional liability: the overlap that surprises
A data breach involving patient records can trigger both cyber-liability claims and professional-liability claims if the breach resulted from inadequate practice security or if the breach affected clinical decision-making (for example, if ransomware locked access to medication records and a dosing error followed). Malpractice policies typically include a small HIPAA-defense sublimit (often $25K to $50K) that is materially below the cost of a real OCR or NY Attorney General investigation. For the coverage-coordination details, see our cyber insurance for NY medical practices explainer and our cyber liability for healthcare guide.
What to review now
At the next renewal, three coverage confirmations carry disproportionate value for a NY physician.
- Limits against current credentialing minimums. If hospital or ACO credentialing has moved to $1.3M/$3.9M and the current policy is still at $1M/$3M, the gap closes at renewal, not mid-term.
- Tail/nose economics at the employment level. Every NY physician employment contract should name the tail-cost owner and reference any free-tail triggers. If the contract is silent, renegotiate at the next amendment window.
- Telehealth endorsement and multi-state licensure alignment. The policy should name every state where telehealth encounters occur, and the physician's licensure should match. For the broader annual-review cadence, our healthcare practice risk checklist covers the coverage lines most often out of alignment.
A 30-minute coverage review against the current policy and employment contract is the highest-ROI malpractice exercise a NY physician runs in any given year, particularly after a practice change, a new hospital affiliation, or a shift in telehealth footprint. To walk through the current state, schedule a consultation with a NY broker who handles physician placement day in and day out.

